HLA Class II Allele Analyses Implicate Common Genetic Components in Type 1 and Non–Insulin-Treated Type 2 Diabetes
Abstract Context Common genetic susceptibility may underlie the frequently observed co-occurrence of type 1 and type 2 diabetes in families. Given the role of HLA class II genes in the pathophysiology of type 1 diabetes, the aim of the present study was to test the association of high density impute...
Saved in:
Published in | The journal of clinical endocrinology and metabolism Vol. 105; no. 3; pp. e245 - e254 |
---|---|
Main Authors | , , , , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
US
Oxford University Press
01.03.2020
Copyright Oxford University Press |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract
Context
Common genetic susceptibility may underlie the frequently observed co-occurrence of type 1 and type 2 diabetes in families. Given the role of HLA class II genes in the pathophysiology of type 1 diabetes, the aim of the present study was to test the association of high density imputed human leukocyte antigen (HLA) genotypes with type 2 diabetes.
Objectives and Design
Three cohorts (Ntotal = 10 413) from Leipzig, Germany were included in this study: LIFE-Adult (N = 4649), LIFE-Heart (N = 4815) and the Sorbs (N = 949) cohort. Detailed metabolic phenotyping and genome-wide single nucleotide polymorphism (SNP) data were available for all subjects. Using 1000 Genome imputation data, HLA genotypes were imputed on 4-digit level and association tests for type 2 diabetes, and related metabolic traits were conducted.
Results
In a meta-analysis including all 3 cohorts, the absence of HLA-DRB5 was associated with increased risk of type 2 diabetes (P = 0.001). In contrast, HLA-DQB*06:02 and HLA-DQA*01:02 had a protective effect on type 2 diabetes (P = 0.005 and 0.003, respectively). Both alleles are part of the well-established type 1 diabetes protective haplotype DRB1*15:01~DQA1*01:02~DQB1*06:02, which was also associated with reduced risk of type 2 diabetes (OR 0.84; P = 0.005). On the contrary, the DRB1*07:01~DQA1*02:01~DQB1*03:03 was identified as a risk haplotype in non–insulin-treated diabetes (OR 1.37; P = 0.002).
Conclusions
Genetic variation in the HLA class II locus exerts risk and protective effects on non–insulin-treated type 2 diabetes. Our data suggest that the genetic architecture of type 1 diabetes and type 2 diabetes might share common components on the HLA class II locus. |
---|---|
AbstractList | Context Common genetic susceptibility may underlie the frequently observed co-occurrence of type 1 and type 2 diabetes in families. Given the role of HLA class II genes in the pathophysiology of type 1 diabetes, the aim of the present study was to test the association of high density imputed human leukocyte antigen (HLA) genotypes with type 2 diabetes. Objectives and Design Three cohorts (Ntotal = 10 413) from Leipzig, Germany were included in this study: LIFE-Adult (N = 4649), LIFE-Heart (N = 4815) and the Sorbs (N = 949) cohort. Detailed metabolic phenotyping and genome-wide single nucleotide polymorphism (SNP) data were available for all subjects. Using 1000 Genome imputation data, HLA genotypes were imputed on 4-digit level and association tests for type 2 diabetes, and related metabolic traits were conducted. Results In a meta-analysis including all 3 cohorts, the absence of HLA-DRB5 was associated with increased risk of type 2 diabetes (P = 0.001). In contrast, HLA-DQB*06:02 and HLA-DQA*01:02 had a protective effect on type 2 diabetes (P = 0.005 and 0.003, respectively). Both alleles are part of the well-established type 1 diabetes protective haplotype DRB1*15:01~DQA1*01:02~DQB1*06:02, which was also associated with reduced risk of type 2 diabetes (OR 0.84; P = 0.005). On the contrary, the DRB1*07:01~DQA1*02:01~DQB1*03:03 was identified as a risk haplotype in non–insulin-treated diabetes (OR 1.37; P = 0.002). Conclusions Genetic variation in the HLA class II locus exerts risk and protective effects on non–insulin-treated type 2 diabetes. Our data suggest that the genetic architecture of type 1 diabetes and type 2 diabetes might share common components on the HLA class II locus. Common genetic susceptibility may underlie the frequently observed co-occurrence of type 1 and type 2 diabetes in families. Given the role of HLA class II genes in the pathophysiology of type 1 diabetes, the aim of the present study was to test the association of high density imputed human leukocyte antigen (HLA) genotypes with type 2 diabetes. Three cohorts (Ntotal = 10 413) from Leipzig, Germany were included in this study: LIFE-Adult (N = 4649), LIFE-Heart (N = 4815) and the Sorbs (N = 949) cohort. Detailed metabolic phenotyping and genome-wide single nucleotide polymorphism (SNP) data were available for all subjects. Using 1000 Genome imputation data, HLA genotypes were imputed on 4-digit level and association tests for type 2 diabetes, and related metabolic traits were conducted. In a meta-analysis including all 3 cohorts, the absence of HLA-DRB5 was associated with increased risk of type 2 diabetes (P = 0.001). In contrast, HLA-DQB*06:02 and HLA-DQA*01:02 had a protective effect on type 2 diabetes (P = 0.005 and 0.003, respectively). Both alleles are part of the well-established type 1 diabetes protective haplotype DRB1*15:01~DQA1*01:02~DQB1*06:02, which was also associated with reduced risk of type 2 diabetes (OR 0.84; P = 0.005). On the contrary, the DRB1*07:01~DQA1*02:01~DQB1*03:03 was identified as a risk haplotype in non-insulin-treated diabetes (OR 1.37; P = 0.002). Genetic variation in the HLA class II locus exerts risk and protective effects on non-insulin-treated type 2 diabetes. Our data suggest that the genetic architecture of type 1 diabetes and type 2 diabetes might share common components on the HLA class II locus. Common genetic susceptibility may underlie the frequently observed co-occurrence of type 1 and type 2 diabetes in families. Given the role of HLA class II genes in the pathophysiology of type 1 diabetes, the aim of the present study was to test the association of high density imputed human leukocyte antigen (HLA) genotypes with type 2 diabetes.CONTEXTCommon genetic susceptibility may underlie the frequently observed co-occurrence of type 1 and type 2 diabetes in families. Given the role of HLA class II genes in the pathophysiology of type 1 diabetes, the aim of the present study was to test the association of high density imputed human leukocyte antigen (HLA) genotypes with type 2 diabetes.Three cohorts (Ntotal = 10 413) from Leipzig, Germany were included in this study: LIFE-Adult (N = 4649), LIFE-Heart (N = 4815) and the Sorbs (N = 949) cohort. Detailed metabolic phenotyping and genome-wide single nucleotide polymorphism (SNP) data were available for all subjects. Using 1000 Genome imputation data, HLA genotypes were imputed on 4-digit level and association tests for type 2 diabetes, and related metabolic traits were conducted.OBJECTIVES AND DESIGNThree cohorts (Ntotal = 10 413) from Leipzig, Germany were included in this study: LIFE-Adult (N = 4649), LIFE-Heart (N = 4815) and the Sorbs (N = 949) cohort. Detailed metabolic phenotyping and genome-wide single nucleotide polymorphism (SNP) data were available for all subjects. Using 1000 Genome imputation data, HLA genotypes were imputed on 4-digit level and association tests for type 2 diabetes, and related metabolic traits were conducted.In a meta-analysis including all 3 cohorts, the absence of HLA-DRB5 was associated with increased risk of type 2 diabetes (P = 0.001). In contrast, HLA-DQB*06:02 and HLA-DQA*01:02 had a protective effect on type 2 diabetes (P = 0.005 and 0.003, respectively). Both alleles are part of the well-established type 1 diabetes protective haplotype DRB1*15:01~DQA1*01:02~DQB1*06:02, which was also associated with reduced risk of type 2 diabetes (OR 0.84; P = 0.005). On the contrary, the DRB1*07:01~DQA1*02:01~DQB1*03:03 was identified as a risk haplotype in non-insulin-treated diabetes (OR 1.37; P = 0.002).RESULTSIn a meta-analysis including all 3 cohorts, the absence of HLA-DRB5 was associated with increased risk of type 2 diabetes (P = 0.001). In contrast, HLA-DQB*06:02 and HLA-DQA*01:02 had a protective effect on type 2 diabetes (P = 0.005 and 0.003, respectively). Both alleles are part of the well-established type 1 diabetes protective haplotype DRB1*15:01~DQA1*01:02~DQB1*06:02, which was also associated with reduced risk of type 2 diabetes (OR 0.84; P = 0.005). On the contrary, the DRB1*07:01~DQA1*02:01~DQB1*03:03 was identified as a risk haplotype in non-insulin-treated diabetes (OR 1.37; P = 0.002).Genetic variation in the HLA class II locus exerts risk and protective effects on non-insulin-treated type 2 diabetes. Our data suggest that the genetic architecture of type 1 diabetes and type 2 diabetes might share common components on the HLA class II locus.CONCLUSIONSGenetic variation in the HLA class II locus exerts risk and protective effects on non-insulin-treated type 2 diabetes. Our data suggest that the genetic architecture of type 1 diabetes and type 2 diabetes might share common components on the HLA class II locus. Abstract Context Common genetic susceptibility may underlie the frequently observed co-occurrence of type 1 and type 2 diabetes in families. Given the role of HLA class II genes in the pathophysiology of type 1 diabetes, the aim of the present study was to test the association of high density imputed human leukocyte antigen (HLA) genotypes with type 2 diabetes. Objectives and Design Three cohorts (Ntotal = 10 413) from Leipzig, Germany were included in this study: LIFE-Adult (N = 4649), LIFE-Heart (N = 4815) and the Sorbs (N = 949) cohort. Detailed metabolic phenotyping and genome-wide single nucleotide polymorphism (SNP) data were available for all subjects. Using 1000 Genome imputation data, HLA genotypes were imputed on 4-digit level and association tests for type 2 diabetes, and related metabolic traits were conducted. Results In a meta-analysis including all 3 cohorts, the absence of HLA-DRB5 was associated with increased risk of type 2 diabetes (P = 0.001). In contrast, HLA-DQB*06:02 and HLA-DQA*01:02 had a protective effect on type 2 diabetes (P = 0.005 and 0.003, respectively). Both alleles are part of the well-established type 1 diabetes protective haplotype DRB1*15:01~DQA1*01:02~DQB1*06:02, which was also associated with reduced risk of type 2 diabetes (OR 0.84; P = 0.005). On the contrary, the DRB1*07:01~DQA1*02:01~DQB1*03:03 was identified as a risk haplotype in non–insulin-treated diabetes (OR 1.37; P = 0.002). Conclusions Genetic variation in the HLA class II locus exerts risk and protective effects on non–insulin-treated type 2 diabetes. Our data suggest that the genetic architecture of type 1 diabetes and type 2 diabetes might share common components on the HLA class II locus. |
Author | Schuch, Alexander Thiery, Joachim Engel, Christoph Scholz, Markus Massier, Lucas Tönjes, Anke Ahnert, Peter Jacobi, Thomas Blüher, Matthias Horn, Katrin Kovacs, Peter Löffler, Markus Doxiadis, Ilias Klöting, Nora Burkhardt, Ralph Stumvoll, Michael |
AuthorAffiliation | University of Leipzig Medical Center, IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany LIFE Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany Institute of Laboratory Medicine and Clinical Chemistry, University of Leipzig, Leipzig, Germany Medical Department III – Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, Germany Institute for Transfusion Medicine, University Hospital of Leipzig, Leipzig, Germany |
AuthorAffiliation_xml | – name: University of Leipzig Medical Center, IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany LIFE Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany Institute of Clinical Chemistry and Laboratory Medicine, University Hospital Regensburg, Regensburg, Germany Institute of Laboratory Medicine and Clinical Chemistry, University of Leipzig, Leipzig, Germany Medical Department III – Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, Germany Institute for Transfusion Medicine, University Hospital of Leipzig, Leipzig, Germany |
Author_xml | – sequence: 1 givenname: Thomas surname: Jacobi fullname: Jacobi, Thomas organization: University of Leipzig Medical Center, IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany – sequence: 2 givenname: Lucas surname: Massier fullname: Massier, Lucas organization: University of Leipzig Medical Center, IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany – sequence: 3 givenname: Nora surname: Klöting fullname: Klöting, Nora organization: University of Leipzig Medical Center, IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany – sequence: 4 givenname: Katrin surname: Horn fullname: Horn, Katrin organization: Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany – sequence: 5 givenname: Alexander surname: Schuch fullname: Schuch, Alexander organization: Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany – sequence: 6 givenname: Peter surname: Ahnert fullname: Ahnert, Peter organization: Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany – sequence: 7 givenname: Christoph surname: Engel fullname: Engel, Christoph organization: Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany – sequence: 8 givenname: Markus surname: Löffler fullname: Löffler, Markus organization: Institute for Medical Informatics, Statistics and Epidemiology, University of Leipzig, Leipzig, Germany – sequence: 9 givenname: Ralph surname: Burkhardt fullname: Burkhardt, Ralph organization: LIFE Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany – sequence: 10 givenname: Joachim surname: Thiery fullname: Thiery, Joachim organization: LIFE Research Centre for Civilization Diseases, University of Leipzig, Leipzig, Germany – sequence: 11 givenname: Anke surname: Tönjes fullname: Tönjes, Anke organization: Medical Department III – Endocrinology, Nephrology, Rheumatology, University of Leipzig Medical Center, Leipzig, Germany – sequence: 12 givenname: Michael surname: Stumvoll fullname: Stumvoll, Michael organization: University of Leipzig Medical Center, IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany – sequence: 13 givenname: Matthias surname: Blüher fullname: Blüher, Matthias organization: University of Leipzig Medical Center, IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany – sequence: 14 givenname: Ilias surname: Doxiadis fullname: Doxiadis, Ilias organization: Institute for Transfusion Medicine, University Hospital of Leipzig, Leipzig, Germany – sequence: 15 givenname: Markus surname: Scholz fullname: Scholz, Markus organization: University of Leipzig Medical Center, IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany – sequence: 16 givenname: Peter orcidid: 0000-0002-0290-5423 surname: Kovacs fullname: Kovacs, Peter email: peter.kovacs@medizin.uni-leipzig.de organization: University of Leipzig Medical Center, IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/31974565$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkc9qGzEQh0VJSZw01x6LoJf2sIn-7co-GqdNDKa5ONCbkFezjVKttJW0BN_6Dn3DPkkV1rkEQk9Co-8bDb85RUc-eEDoPSUXlFFy2Trrob80P7QmTL5BM7oQdSXpQh6hGSGMVgvJvp-g05QeCKFC1PwYnfDyLuqmnqF8s1nildMp4fUaL50DB3jptdsnKKV-cLbVGfAq9H3w-Bo8ZNs-XYcyiM8JW4-3-wEwxdob_C34v7__rH0ay2DVNkKRzQQwfGX1DjKkd-htp12C88N5hu6-ftmubqrN7fV6tdxUrSBEVrLtOm5auQBCdNOQuaCcdqaZAyVNLRhh2jSMciPnRJRSCYTKel6Lne6EEIafoU9T3yGGXyOkrHqbWnBOewhjUowLwaRouCzoxxfoQxhjyaFQgtOSbU1IoT4cqHHXg1FDtL2Oe_WcZwHEBLQxpBShU63NOtvgc9TWKUrU09rUtDZ1WFvRLl5oz51fFdgkPAaXIaafbnyEqO5Bu3z_uvR5ksI4_O-DfyrRuhQ |
CitedBy_id | crossref_primary_10_2174_1871530323666221111153102 crossref_primary_10_3390_genes13050772 crossref_primary_10_2337_dc21_1238 crossref_primary_10_1155_2022_9710376 crossref_primary_10_3390_jcm11061690 crossref_primary_10_1007_s10142_022_00881_5 crossref_primary_10_3389_fendo_2022_842673 crossref_primary_10_3389_fnins_2020_00670 crossref_primary_10_3390_ijms23126481 crossref_primary_10_1016_j_metabol_2024_155917 crossref_primary_10_1371_journal_pone_0275934 crossref_primary_10_3389_fimmu_2024_1501660 |
Cites_doi | 10.1371/journal.pcbi.1002877 10.1186/1471-2156-12-67 10.1111/j.1744-313X.2006.00581.x 10.1155/2013/452537 10.1086/282771 10.1002/jmri.26754 10.1097/MD.0000000000003858 10.1084/jem.179.1.279 10.2337/db07-1331 10.1016/j.cmet.2013.02.009 10.2337/db16-1253 10.1093/nar/gku1166 10.1038/srep35005 10.2337/db15-1115 10.1007/BF00399956 10.2337/db18-0501 10.1007/s00125-016-4139-5 10.4049/jimmunol.160.7.3363 10.3389/fimmu.2017.00984 10.2337/diacare.24.4.796 10.2337/dc18-S002 10.1093/hmg/ddp423 10.2337/diabetes.48.1.150 10.1373/clinchem.2010.148270 10.2337/db13-1153 10.1111/cei.12687 10.1038/tpj.2013.18 10.4049/jimmunol.159.2.703 10.1371/journal.pone.0172444 10.7717/peerj.281 10.1038/ng1885 10.3324/haematol.2017.179119 10.1007/s00125-011-2122-8 10.2337/diabetes.48.5.983 10.1371/journal.pone.0029070 10.1111/j.1745-7599.2009.00399.x 10.1038/ng.3943 10.1186/s12889-015-1983-z 10.1371/journal.pgen.1005510 10.1016/S0198-8859(99)00146-9 10.1111/j.1463-1326.2008.00950.x 10.1007/s00125-006-0513-z 10.1007/s001250051202 10.1016/0197-2456(86)90046-2 10.1210/jc.2003-032084 10.1016/j.celrep.2014.09.004 10.2337/diabetes.54.suppl_2.S40 10.1007/s00251-011-0513-0 10.1016/S2213-8587(18)30051-2 10.1136/bmj.307.6897.155 10.1002/sim.1186 10.1016/j.humimm.2015.12.006 10.1007/s00125-003-1070-3 10.1007/BF00280883 10.2337/dc08-s243 10.4049/jimmunol.153.4.1665 10.1089/152091504774198124 10.4049/jimmunol.160.5.2365 10.1038/ejhg.2009.107 10.1016/j.clim.2005.08.017 10.1093/bioinformatics/bty633 10.1007/BF00401370 |
ContentType | Journal Article |
Copyright | Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 Copyright © Oxford University Press 2015 Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
Copyright_xml | – notice: Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com 2020 – notice: Copyright © Oxford University Press 2015 – notice: Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
DBID | AAYXX CITATION NPM 3V. 7QP 7T5 7TM 7X7 7XB 88E 8FI 8FJ 8FK ABUWG AFKRA BENPR CCPQU FYUFA GHDGH H94 K9. M0S M1P PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQQKQ PQUKI PRINS 7X8 |
DOI | 10.1210/clinem/dgaa027 |
DatabaseName | CrossRef PubMed ProQuest Central (Corporate) Calcium & Calcified Tissue Abstracts Immunology Abstracts Nucleic Acids Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central UK/Ireland ProQuest Central ProQuest One Health Research Premium Collection Health Research Premium Collection (Alumni) AIDS and Cancer Research Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Health & Medical Collection Medical Database ProQuest Central Premium ProQuest One Academic ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic |
DatabaseTitle | CrossRef PubMed ProQuest One Academic Middle East (New) Nucleic Acids Abstracts ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing ProQuest Central China ProQuest Central ProQuest Health & Medical Research Collection Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Health & Medical Research Collection AIDS and Cancer Research Abstracts ProQuest Central (New) ProQuest Medical Library (Alumni) ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition Immunology Abstracts ProQuest One Academic Calcium & Calcified Tissue Abstracts ProQuest One Academic (New) ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | ProQuest One Academic Middle East (New) PubMed MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1945-7197 |
EndPage | e254 |
ExternalDocumentID | 31974565 10_1210_clinem_dgaa027 10.1210/clinem/dgaa027 |
Genre | Journal Article |
GroupedDBID | --- -~X .55 .GJ .XZ 08P 0R~ 18M 1TH 29K 2WC 34G 354 39C 3O- 4.4 48X 53G 5GY 5RS 5YH 7X7 88E 8F7 8FI 8FJ AABZA AACZT AAIMJ AAJQQ AAKAS AAPGJ AAPQZ AAPXW AAQQT AARHZ AAUAY AAUQX AAVAP AAWDT AAWTL AAYJJ ABBLC ABDFA ABDPE ABEJV ABGNP ABJNI ABLJU ABMNT ABNHQ ABOCM ABPMR ABPPZ ABPQP ABPTD ABQNK ABUWG ABVGC ABWST ABXVV ABXZS ACFRR ACGFO ACGFS ACPRK ACUTJ ACVCV ACYHN ACZBC ADBBV ADGKP ADGZP ADHKW ADMTO ADNBA ADQBN ADRTK ADVEK ADZCM AELWJ AEMDU AEMQT AENEX AENZO AERZD AETBJ AEWNT AFCHL AFFNX AFFQV AFFZL AFGWE AFKRA AFOFC AFRAH AFXAL AFYAG AGINJ AGKRT AGMDO AGQXC AGUTN AHMBA AHMMS AI. AJDVS AJEEA ALMA_UNASSIGNED_HOLDINGS ALXQX APIBT APJGH AQDSO AQKUS ARIXL ASPBG ATGXG AVNTJ AVWKF AZFZN BAWUL BAYMD BCRHZ BENPR BEYMZ BPHCQ BSWAC BTRTY BVXVI C45 CCPQU CDBKE CS3 D-I DAKXR DIK E3Z EBS EIHJH EJD EMOBN ENERS F5P FECEO FEDTE FHSFR FLUFQ FOEOM FOTVD FQBLK FYUFA GAUVT GJXCC GX1 H13 HMCUK HVGLF HZ~ H~9 IAO IHR INH ITC J5H KBUDW KOP KSI KSN L7B M1P M5~ MBLQV MHKGH MJL N4W N9A NLBLG NOMLY NOYVH NVLIB O9- OAUYM OBFPC OBH OCB ODMLO OFXIZ OGEVE OHH OJZSN OK1 OPAEJ OVD OVIDX P2P P6G PHGZT PQQKQ PROAC PSQYO REU ROX ROZ TEORI TJX TLC TMA TR2 TWZ UKHRP VH1 VVN W8F WHG WOQ X52 X7M YBU YFH YHG YOC YSK ZGI ZXP ZY1 ~02 ~H1 AEOTA AGORE AJBYB NU- PHGZM AAYXX AHGBF CITATION KQ8 NPM 3V. 7QP 7T5 7TM 7XB 8FK H94 K9. PJZUB PKEHL PPXIY PQEST PQUKI PRINS 7X8 |
ID | FETCH-LOGICAL-c4007-7cff3dc79e00a66084131fd68e10654202ad6213d7804106121175854baf444d3 |
IEDL.DBID | 7X7 |
ISSN | 0021-972X 1945-7197 |
IngestDate | Thu Jul 10 22:22:13 EDT 2025 Fri Jul 25 21:59:26 EDT 2025 Wed Feb 19 02:31:14 EST 2025 Tue Jul 01 01:10:55 EDT 2025 Thu Apr 24 22:58:24 EDT 2025 Fri May 16 03:41:27 EDT 2025 Wed Apr 02 07:02:00 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 3 |
Keywords | type 1 diabetes haplotype type 2 diabetes single nucleotide polymorphism genotype imputation HLA class II association |
Language | English |
License | This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model) https://academic.oup.com/journals/pages/open_access/funder_policies/chorus/standard_publication_model Endocrine Society 2020. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c4007-7cff3dc79e00a66084131fd68e10654202ad6213d7804106121175854baf444d3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 content type line 23 |
ORCID | 0000-0002-0290-5423 |
PMID | 31974565 |
PQID | 2431027500 |
PQPubID | 2046206 |
ParticipantIDs | proquest_miscellaneous_2344274637 proquest_journals_2431027500 pubmed_primary_31974565 crossref_citationtrail_10_1210_clinem_dgaa027 crossref_primary_10_1210_clinem_dgaa027 wolterskluwer_health_10_1210_clinem_dgaa027 oup_primary_10_1210_clinem_dgaa027 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2020-03-01 |
PublicationDateYYYYMMDD | 2020-03-01 |
PublicationDate_xml | – month: 03 year: 2020 text: 2020-03-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | US |
PublicationPlace_xml | – name: US – name: United States – name: Washington |
PublicationTitle | The journal of clinical endocrinology and metabolism |
PublicationTitleAlternate | J Clin Endocrinol Metab |
PublicationYear | 2020 |
Publisher | Oxford University Press Copyright Oxford University Press |
Publisher_xml | – name: Oxford University Press – name: Copyright Oxford University Press |
References | Stumvoll (2021122102015822900_CIT0032) 2001; 24 Karnes (2021122102015822900_CIT0016) 2017; 12 Raddrizzani (2021122102015822900_CIT0062) 1997; 159 Loeffler (2021122102015822900_CIT0017) 2015; 15 Nomura (2021122102015822900_CIT0041) 2006; 33 de Bakker (2021122102015822900_CIT0015) 2006; 38 R Core Team (2021122102015822900_CIT0025) 2018 Sanjeevi (2021122102015822900_CIT0038) 2000; 61 Nei (2021122102015822900_CIT0027) 1972; 106 Donath (2021122102015822900_CIT0049) 2008; 31 Suppl 2 Astill (2021122102015822900_CIT0055) 2003; 46 Lambert (2021122102015822900_CIT0003) 2004; 89 González-Galarza (2021122102015822900_CIT0026) 2015; 43 Tuomi (2021122102015822900_CIT0053) 1999; 48 van Lummel (2021122102015822900_CIT0066) 2019; 68 Brooks-Worrell (2021122102015822900_CIT0043) 1999; 48 Böni-Schnetzler (2021122102015822900_CIT0048) 2008; 10 Williams (2021122102015822900_CIT0013) 2011; 54 Beutner (2021122102015822900_CIT0018) 2011; 6 Gross (2021122102015822900_CIT0023) 2011; 12 Hrdinová (2021122102015822900_CIT0057) 2018; 103 Guo (2021122102015822900_CIT0011) 2016; 6 Horton (2021122102015822900_CIT0010) 1999; 42 Paradis (2021122102015822900_CIT0029) 2019; 35 Schwarzer (2021122102015822900_CIT0034) 2007; 7 Zavala (2021122102015822900_CIT0044) 1992; 35 Tönjes (2021122102015822900_CIT0021) 2010; 18 Cho (2021122102015822900_CIT0005) 2014; 9 Pfützner (2021122102015822900_CIT0065) 2004; 6 Ma (2021122102015822900_CIT0040) 2013; 2013 Tönjes (2021122102015822900_CIT0020) 2009; 18 DerSimonian (2021122102015822900_CIT0035) 1986; 7 Roark (2021122102015822900_CIT0039) 2014; 63 Rich (2021122102015822900_CIT0008) 1993; 36 Wucherpfennig (2021122102015822900_CIT0061) 1994; 179 Ahlqvist (2021122102015822900_CIT0006) 2018; 6 Erlich (2021122102015822900_CIT0054) 2008; 57 Barbosa (2021122102015822900_CIT0058) 2006; 118 Pappas (2021122102015822900_CIT0037) 2016; 77 de Vries (2021122102015822900_CIT0056) 2017; 60 Massier (2021122102015822900_CIT0050) Southwood (2021122102015822900_CIT0059) 1998; 160 American Diabetes Association 2 (2021122102015822900_CIT0022) 2018; 41 Zhao (2021122102015822900_CIT0014) 2017; 49 Viechtbauer (2021122102015822900_CIT0033) 2010 Chen (2021122102015822900_CIT0046) 2019; 50 Vogt (2021122102015822900_CIT0060) 1994; 153 Tuomilehto-Wolf (2021122102015822900_CIT0009) 1993; 307 Matthews (2021122102015822900_CIT0031) 1985; 28 Tuomi (2021122102015822900_CIT0007) 2005; 54 Suppl 2 Desai (2021122102015822900_CIT0002) 2007; 50 Deng (2021122102015822900_CIT0004) 2013; 17 Zheng (2021122102015822900_CIT0030) 2014; 14 Gibson (2021122102015822900_CIT0064) 2015; 182 Scott (2021122102015822900_CIT0012) 2017; 66 Zhao (2021122102015822900_CIT0051) 2016; 65 Appel (2021122102015822900_CIT0042) 2009; 21 Brooks-Worrell (2021122102015822900_CIT0045) 2011; 57 Ettinger (2021122102015822900_CIT0063) 1998; 160 Greenbaum (2021122102015822900_CIT0001) 2011; 63 Dilthey (2021122102015822900_CIT0024) 2013; 9 Burkhardt (2021122102015822900_CIT0019) 2015; 11 Higgins (2021122102015822900_CIT0036) 2002; 21 Scholz (2021122102015822900_CIT0052) 2017; 8 Kamvar (2021122102015822900_CIT0028) 2014; 2 Dong (2021122102015822900_CIT0047) 2016; 95 |
References_xml | – volume: 9 start-page: e1002877 issue: 2 year: 2013 ident: 2021122102015822900_CIT0024 article-title: Multi-population classical HLA type imputation publication-title: Plos Comput Biol. doi: 10.1371/journal.pcbi.1002877 – volume: 12 start-page: 67 year: 2011 ident: 2021122102015822900_CIT0023 article-title: Population-genetic comparison of the Sorbian isolate population in Germany with the German KORA population using genome-wide SNP arrays publication-title: BMC Genet. doi: 10.1186/1471-2156-12-67 – volume: 33 start-page: 117 issue: 2 year: 2006 ident: 2021122102015822900_CIT0041 article-title: Genetic analysis of HLA, NA and HPA typing in type 2 diabetes and ASO publication-title: Int J Immunogenet. doi: 10.1111/j.1744-313X.2006.00581.x – volume: 2013 start-page: 452537 year: 2013 ident: 2021122102015822900_CIT0040 article-title: Association of the HLA-DQA1 and HLA-DQB1 alleles in type 2 diabetes mellitus and diabetic nephropathy in the han ethnicity of China publication-title: J Diabetes Res. doi: 10.1155/2013/452537 – volume: 106 start-page: 283 year: 1972 ident: 2021122102015822900_CIT0027 article-title: Genetic distance between populations publication-title: The American Naturalist doi: 10.1086/282771 – volume: 50 start-page: 1905 issue: 6 year: 2019 ident: 2021122102015822900_CIT0046 article-title: Magnetic resonance imaging: proton density fat fraction for assessment of pancreatic fatty infiltration during progression of T2DM bama minipigs publication-title: J Magn Reson Imaging doi: 10.1002/jmri.26754 – volume: 95 issue: 23 year: 2016 ident: 2021122102015822900_CIT0047 article-title: Noninvasive fat quantification of the liver and pancreas may provide potential biomarkers of impaired glucose tolerance and type 2 diabetes publication-title: Medicine (Baltimore) doi: 10.1097/MD.0000000000003858 – volume: 179 start-page: 279 year: 1994 ident: 2021122102015822900_CIT0061 article-title: Structural requirements for binding of an immunodominant myelin basic protein peptide to DR2 isotypes and for its recognition by human T cell clones publication-title: Journal of Experimental Medicine doi: 10.1084/jem.179.1.279 – volume: 57 start-page: 1084 issue: 4 year: 2008 ident: 2021122102015822900_CIT0054 article-title: HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 diabetes genetics consortium families publication-title: Diabetes. doi: 10.2337/db07-1331 – volume: 17 start-page: 411 issue: 3 year: 2013 ident: 2021122102015822900_CIT0004 article-title: Class II major histocompatibility complex plays an essential role in obesity-induced adipose inflammation publication-title: Cell Metab. doi: 10.1016/j.cmet.2013.02.009 – volume: 66 start-page: 2888 issue: 11 year: 2017 ident: 2021122102015822900_CIT0012 article-title: An expanded genome-wide association study of type 2 diabetes in Europeans publication-title: Diabetes. doi: 10.2337/db16-1253 – volume: 43 start-page: D784 issue: Database issue year: 2015 ident: 2021122102015822900_CIT0026 article-title: Allele frequency net 2015 update: new features for HLA epitopes, KIR and disease and HLA adverse drug reaction associations publication-title: Nucleic Acids Res. doi: 10.1093/nar/gku1166 – volume: 6 start-page: 35005 year: 2016 ident: 2021122102015822900_CIT0011 article-title: The relationships between HLA class II alleles and antigens with gestational diabetes mellitus: a meta-analysis publication-title: Sci Rep. doi: 10.1038/srep35005 – volume: 65 start-page: 710 issue: 3 year: 2016 ident: 2021122102015822900_CIT0051 article-title: Next-generation sequencing reveals that HLA-DRB3, -DRB4, and -DRB5 may be associated with islet autoantibodies and risk for childhood type 1 diabetes publication-title: Diabetes. doi: 10.2337/db15-1115 – volume: 36 start-page: 234 issue: 3 year: 1993 ident: 2021122102015822900_CIT0008 article-title: HLA-associated susceptibility to type 2 (non-insulin-dependent) diabetes mellitus: the Wadena City Health Study publication-title: Diabetologia. doi: 10.1007/BF00399956 – volume: 68 start-page: 787 issue: 4 year: 2019 ident: 2021122102015822900_CIT0066 article-title: Epitope stealing as a mechanism of dominant protection by HLA-DQ6 in type 1 diabetes publication-title: Diabetes. doi: 10.2337/db18-0501 – volume: 60 start-page: 280 year: 2017 ident: 2021122102015822900_CIT0056 article-title: ADAMTS13 activity as a novel risk factor for incident type 2 diabetes mellitus: a population-based cohort study publication-title: Diabetologia doi: 10.1007/s00125-016-4139-5 – volume: 160 start-page: 3363 year: 1998 ident: 2021122102015822900_CIT0059 article-title: Several common HLA-DR types share largely overlapping peptide binding repertoires publication-title: The Journal of Immunology doi: 10.4049/jimmunol.160.7.3363 – volume: 8 start-page: 984 year: 2017 ident: 2021122102015822900_CIT0052 article-title: Human leukocyte antigen (HLA)-DRB1*15:01 and HLA-DRB5*01:01 present complementary peptide repertoires publication-title: Front Immunol. doi: 10.3389/fimmu.2017.00984 – volume: 24 start-page: 796 issue: 4 year: 2001 ident: 2021122102015822900_CIT0032 article-title: Oral glucose tolerance test indexes for insulin sensitivity and secretion based on various availabilities of sampling times publication-title: Diabetes Care. doi: 10.2337/diacare.24.4.796 – volume: 41 start-page: S13 year: 2018 ident: 2021122102015822900_CIT0022 article-title: Classification and diagnosis of diabetes: standards of medical care in diabetes—2018 publication-title: Diabetes Care doi: 10.2337/dc18-S002 – volume: 18 start-page: 4662 issue: 23 year: 2009 ident: 2021122102015822900_CIT0020 article-title: Genetic variation in GPR133 is associated with height: genome wide association study in the self-contained population of Sorbs publication-title: Hum Mol Genet. doi: 10.1093/hmg/ddp423 – volume: 48 start-page: 150 issue: 1 year: 1999 ident: 2021122102015822900_CIT0053 article-title: Clinical and genetic characteristics of type 2 diabetes with and without GAD antibodies publication-title: Diabetes. doi: 10.2337/diabetes.48.1.150 – volume: 57 start-page: 158 issue: 2 year: 2011 ident: 2021122102015822900_CIT0045 article-title: Is diabetes mellitus a continuous spectrum? publication-title: Clin Chem. doi: 10.1373/clinchem.2010.148270 – volume: 63 start-page: 323 issue: 1 year: 2014 ident: 2021122102015822900_CIT0039 article-title: Multiple HLA epitopes contribute to type 1 diabetes susceptibility publication-title: Diabetes. doi: 10.2337/db13-1153 – volume: 182 start-page: 251 issue: 3 year: 2015 ident: 2021122102015822900_CIT0064 article-title: Proinsulin multi-peptide immunotherapy induces antigen-specific regulatory T cells and limits autoimmunity in a humanized model publication-title: Clin Exp Immunol. doi: 10.1111/cei.12687 – volume: 14 start-page: 192 issue: 2 year: 2014 ident: 2021122102015822900_CIT0030 article-title: HIBAG–HLA genotype imputation with attribute bagging publication-title: Pharmacogenomics J. doi: 10.1038/tpj.2013.18 – volume: 159 start-page: 703 year: 1997 ident: 2021122102015822900_CIT0062 article-title: Different modes of peptide interaction enable HLA-DQ and HLA-DR molecules to bind diverse peptide repertoires publication-title: The Journal of Immunology doi: 10.4049/jimmunol.159.2.703 – volume: 12 start-page: e0172444 issue: 2 year: 2017 ident: 2021122102015822900_CIT0016 article-title: Comparison of HLA allelic imputation programs publication-title: Plos One. doi: 10.1371/journal.pone.0172444 – volume: 2 start-page: e281 year: 2014 ident: 2021122102015822900_CIT0028 article-title: Poppr: an R package for genetic analysis of populations with clonal, partially clonal, and/or sexual reproduction publication-title: Peerj. doi: 10.7717/peerj.281 – volume: 38 start-page: 1166 issue: 10 year: 2006 ident: 2021122102015822900_CIT0015 article-title: A high-resolution HLA and SNP haplotype map for disease association studies in the extended human MHC publication-title: Nat Genet. doi: 10.1038/ng1885 – volume: 103 start-page: 1083 issue: 6 year: 2018 ident: 2021122102015822900_CIT0057 article-title: Mass spectrometry-assisted identification of ADAMTS13-derived peptides presented on HLA-DR and HLA-DQ publication-title: Haematologica. doi: 10.3324/haematol.2017.179119 – volume: 54 start-page: 1684 issue: 7 year: 2011 ident: 2021122102015822900_CIT0013 article-title: HLA-DRB1 reduces the risk of type 2 diabetes mellitus by increased insulin secretion publication-title: Diabetologia. doi: 10.1007/s00125-011-2122-8 – volume: 48 start-page: 983 issue: 5 year: 1999 ident: 2021122102015822900_CIT0043 article-title: Cellular immune responses to human islet proteins in antibody- positive type 2 diabetic patients publication-title: Diabetes. doi: 10.2337/diabetes.48.5.983 – volume-title: R: A Language and Environment for Statistical Computing year: 2018 ident: 2021122102015822900_CIT0025 – volume: 6 start-page: e29070 issue: 12 year: 2011 ident: 2021122102015822900_CIT0018 article-title: Rationale and design of the Leipzig (LIFE) Heart Study: phenotyping and cardiovascular characteristics of patients with coronary artery disease publication-title: Plos One. doi: 10.1371/journal.pone.0029070 – volume: 21 start-page: 156 issue: 3 year: 2009 ident: 2021122102015822900_CIT0042 article-title: Latent autoimmune diabetes of adulthood (LADA): an often misdiagnosed type of diabetes mellitus publication-title: J Am Acad Nurse Pract. doi: 10.1111/j.1745-7599.2009.00399.x – year: 2010 ident: 2021122102015822900_CIT0033 article-title: Conducting meta-analyses in R with the metafor package – volume: 49 start-page: 1450 issue: 10 year: 2017 ident: 2021122102015822900_CIT0014 article-title: Identification of new susceptibility loci for type 2 diabetes and shared etiological pathways with coronary heart disease publication-title: Nat Genet. doi: 10.1038/ng.3943 – volume: 15 start-page: 691 year: 2015 ident: 2021122102015822900_CIT0017 article-title: The LIFE-Adult-Study: objectives and design of a population-based cohort study with 10 000 deeply phenotyped adults in Germany publication-title: BMC Public Health. doi: 10.1186/s12889-015-1983-z – volume: 11 start-page: e1005510 issue: 9 year: 2015 ident: 2021122102015822900_CIT0019 article-title: Integration of genome-wide SNP data and gene-expression profiles reveals six novel loci and regulatory mechanisms for amino acids and acylcarnitines in whole blood publication-title: Plos Genet. doi: 10.1371/journal.pgen.1005510 – volume: 61 start-page: 148 issue: 2 year: 2000 ident: 2021122102015822900_CIT0038 article-title: HLA-DQ6-mediated protection in IDDM publication-title: Hum Immunol. doi: 10.1016/S0198-8859(99)00146-9 – volume: 10 start-page: 201 year: 2008 ident: 2021122102015822900_CIT0048 article-title: Insulitis in type 2 diabetes publication-title: Diabetes, Obesity and Metabolism doi: 10.1111/j.1463-1326.2008.00950.x – volume: 50 start-page: 68 issue: 1 year: 2007 ident: 2021122102015822900_CIT0002 article-title: An association analysis of the HLA gene region in latent autoimmune diabetes in adults publication-title: Diabetologia. doi: 10.1007/s00125-006-0513-z – volume: 42 start-page: 608 issue: 5 year: 1999 ident: 2021122102015822900_CIT0010 article-title: Genetic heterogeneity of autoimmune diabetes: age of presentation in adults is influenced by HLA DRB1 and DQB1 genotypes (UKPDS 43). UK Prospective Diabetes Study (UKPDS) Group publication-title: Diabetologia. doi: 10.1007/s001250051202 – volume: 7 start-page: 177 issue: 3 year: 1986 ident: 2021122102015822900_CIT0035 article-title: Meta-analysis in clinical trials publication-title: Control Clin Trials. doi: 10.1016/0197-2456(86)90046-2 – volume: 89 start-page: 4037 issue: 8 year: 2004 ident: 2021122102015822900_CIT0003 article-title: Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom publication-title: J Clin Endocrinol Metab. doi: 10.1210/jc.2003-032084 – volume: 9 start-page: 605 issue: 2 year: 2014 ident: 2021122102015822900_CIT0005 article-title: An MHC II-dependent activation loop between adipose tissue macrophages and CD4+ T cells controls obesity-induced inflammation publication-title: Cell Rep. doi: 10.1016/j.celrep.2014.09.004 – volume: 54 Suppl 2 start-page: S40 year: 2005 ident: 2021122102015822900_CIT0007 article-title: Type 1 and type 2 diabetes: what do they have in common? publication-title: Diabetes. doi: 10.2337/diabetes.54.suppl_2.S40 – volume: 7 start-page: 40 year: 2007 ident: 2021122102015822900_CIT0034 article-title: meta: an R package for meta-analysis publication-title: R News – volume: 63 start-page: 325 issue: 6 year: 2011 ident: 2021122102015822900_CIT0001 article-title: Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes publication-title: Immunogenetics. doi: 10.1007/s00251-011-0513-0 – volume: 6 start-page: 361 issue: 5 year: 2018 ident: 2021122102015822900_CIT0006 article-title: Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables publication-title: Lancet Diabetes Endocrinol. doi: 10.1016/S2213-8587(18)30051-2 – volume: 307 start-page: 155 issue: 6897 year: 1993 ident: 2021122102015822900_CIT0009 article-title: Genetic susceptibility to non-insulin dependent diabetes mellitus and glucose intolerance are located in HLA region publication-title: Bmj. doi: 10.1136/bmj.307.6897.155 – volume: 21 start-page: 1539 issue: 11 year: 2002 ident: 2021122102015822900_CIT0036 article-title: Quantifying heterogeneity in a meta-analysis publication-title: Stat Med. doi: 10.1002/sim.1186 – volume: 77 start-page: 283 issue: 3 year: 2016 ident: 2021122102015822900_CIT0037 article-title: Bridging immunogenomic data analysis workflow gaps (BIGDAWG): an integrated case-control analysis pipeline publication-title: Hum Immunol. doi: 10.1016/j.humimm.2015.12.006 – volume: 46 start-page: 496 issue: 4 year: 2003 ident: 2021122102015822900_CIT0055 article-title: Promiscuous binding of proinsulin peptides to Type 1 diabetes-permissive and -protective HLA class II molecules publication-title: Diabetologia. doi: 10.1007/s00125-003-1070-3 – volume: 28 start-page: 412 issue: 7 year: 1985 ident: 2021122102015822900_CIT0031 article-title: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man publication-title: Diabetologia. doi: 10.1007/BF00280883 – volume: 31 Suppl 2 start-page: S161 year: 2008 ident: 2021122102015822900_CIT0049 article-title: Islet inflammation in type 2 diabetes: from metabolic stress to therapy publication-title: Diabetes Care. doi: 10.2337/dc08-s243 – volume: 153 start-page: 1665 year: 1994 ident: 2021122102015822900_CIT0060 article-title: Ligand motifs of HLA-DRB5*0101 and DRB1*1501 molecules delineated from self-peptides publication-title: The Journal of Immunology doi: 10.4049/jimmunol.153.4.1665 – volume: 6 start-page: 405 issue: 3 year: 2004 ident: 2021122102015822900_CIT0065 article-title: Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus publication-title: Diabetes Technol Ther. doi: 10.1089/152091504774198124 – volume: 160 start-page: 2365 year: 1998 ident: 2021122102015822900_CIT0063 article-title: A peptide binding Motif for HLA-DQA1*0102/DQB1*0602, the class II MHC molecule associated with dominant protection in insulin-dependent diabetes mellitus publication-title: The Journal of Immunology doi: 10.4049/jimmunol.160.5.2365 – volume: 18 start-page: 104 issue: 1 year: 2010 ident: 2021122102015822900_CIT0021 article-title: Association of FTO variants with BMI and fat mass in the self-contained population of Sorbs in Germany publication-title: Eur J Hum Genet. doi: 10.1038/ejhg.2009.107 – volume: 118 start-page: 42 issue: 1 year: 2006 ident: 2021122102015822900_CIT0058 article-title: Clinical link between MHC class II haplotype and interferon-beta (IFN-beta) immunogenicity publication-title: Clin Immunol. doi: 10.1016/j.clim.2005.08.017 – volume: 35 start-page: 526 issue: 3 year: 2019 ident: 2021122102015822900_CIT0029 article-title: ape 5.0: an environment for modern phylogenetics and evolutionary analyses in R publication-title: Bioinformatics. doi: 10.1093/bioinformatics/bty633 – ident: 2021122102015822900_CIT0050 article-title: Data from: HLA Class II allele analyses implicate common genetic components in type 1 and non–insulin-treated type 2 diabetes. – volume: 35 start-page: 1159 issue: 12 year: 1992 ident: 2021122102015822900_CIT0044 article-title: Cellular and humoural autoimmunity markers in type 2 (non-insulin-dependent) diabetic patients with secondary drug failure publication-title: Diabetologia. doi: 10.1007/BF00401370 |
SSID | ssj0014453 |
Score | 2.4122102 |
Snippet | Abstract
Context
Common genetic susceptibility may underlie the frequently observed co-occurrence of type 1 and type 2 diabetes in families. Given the role of... Common genetic susceptibility may underlie the frequently observed co-occurrence of type 1 and type 2 diabetes in families. Given the role of HLA class II... Context Common genetic susceptibility may underlie the frequently observed co-occurrence of type 1 and type 2 diabetes in families. Given the role of HLA class... |
SourceID | proquest pubmed crossref wolterskluwer oup |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | e245 |
SubjectTerms | Alleles Diabetes Diabetes mellitus (insulin dependent) Diabetes mellitus (non-insulin dependent) DQA1 protein Drb1 protein Gene polymorphism Genetic analysis Genetic diversity Genomes Haplotypes Histocompatibility antigen HLA Insulin Metabolism Phenotyping Single-nucleotide polymorphism |
Title | HLA Class II Allele Analyses Implicate Common Genetic Components in Type 1 and Non–Insulin-Treated Type 2 Diabetes |
URI | https://www.ncbi.nlm.nih.gov/pubmed/31974565 https://www.proquest.com/docview/2431027500 https://www.proquest.com/docview/2344274637 |
Volume | 105 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV1fT9swED_xR0IghAaMrcCQNyHxMFmzY9cpT6hMoBaNakIg9S1yYmdCq5KytuKV78A35JNwl7ilPDAek5wcK3exf-e7-x3AoUylQxRquEvTjGv0IXhLy4wrl5tmemyFshTRveyZzo2-6Df74cBtFNIqp2titVC7MqMz8h8R7nQUYhPiZHjHqWsURVdDC41FWCbqMrLquD9zuNBXCCyUlIYQR_1A2khVK1R36HH0P9YK6igztym9KnSbw5trsH5fUgh79LfKYJ_bh84_wEYAkKxda3wTFnyxBSuXIUS-DePOrzarWl2ybpe1BwPcV1hNPeLxVkgg94wqQ8qCEe00jkSXw7KgrAp2WzDyTplktnCsVxZPD4_dOmWdXxPG9K4WiFjIpxl9hJvzs-ufHR5aK_CMGqHzOMtz5bL42AthjRGoHyVzZ1peVi2sRGSdiaRyFT8RwSCi9Gw1dWpzrbVTO7BU4Kw-AxOOUE8W5UR00_JxaiLn8ryptLNaetkAPv22SRZ4x6n9xSAh_wN1kdS6SIIuGnA0kx_WjBtvSn5DVb0rtD_VZBJ-z1HyYkwN-Dp7jD8WRUts4csJyiit0WU3Cof4VFvA7FW4bsUEhRvw_ZVJJHXx6htT2f3_VPZgNSJnvkpw24el8b-J_4KIZ5weVGZ9AMunZ73fV8_2wQET |
linkProvider | ProQuest |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1fb9MwED-NIfFHCPFvUBhgEIgHZM12XKd7QKgCpoa1feqkvmVO7CBElXRrp2lv-w58Dz4Un4S7xCndw-Bpj0lOzsV3se98d78DeCMz6dAKNdxlWc41-hC8p2XOI1eYbrZrRWQpojsam8GB_jrtTjfgV1sLQ2mV7ZpYL9SuyumMfEfhTkchNiE-zo84dY2i6GrbQqNRi31_doou2-JD8hnl-1apvS-TTwMeugrwnHqA8zgvisjl8a4XwhojkLVIFs70vKy7NwllnVEycjU0D1kAhGbZ6-rMFlprF-G41-A6sUPOXjxdOXjomwTUS0p7iNU0gERSlQzVOXr8mm_WCupgs7YJXiisW7Nvb8Od04pC5osfdcb82r63dw_uBoOV9RsNuw8bvnwAN0YhJP8QloNhn9WtNVmSsP5shvsYa6BOPN4KCeueUSVKVTKCucaR6HJelZTFwb6XjLxhJpktHRtX5e_zn0mTIs8nZNN61xAoFvJ3Fo_g4EomfQs2S-TqCTDhyMrKVUHAOj0fZ0Y5VxTdSDurpZcd4O3cpnnAOad2G7OU_B2URdrIIg2y6MC7Ff28Qfi4lPI1iuq_RNutJNOwHCzSv8rbgVerx_gjU3TGlr46QZpIaxVrE-EQjxsNWL0K18mYTO8OvL-gEmlTLHsJK0__zcpLuDmYjIbpMBnvP4Nbig4S6uS6bdhcHp_452htLbMXtYozOLzqf-oP_AM4wA |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HLA+Class+II+Allele+Analyses+Implicate+Common+Genetic+Components+in+Type+1+and+Non%E2%80%93Insulin-Treated+Type+2+Diabetes&rft.jtitle=The+journal+of+clinical+endocrinology+and+metabolism&rft.au=Jacobi%2C+Thomas&rft.au=Lucas+Massier&rft.au=Kl%C3%B6ting%2C+Nora&rft.au=Horn%2C+Katrin&rft.date=2020-03-01&rft.pub=Oxford+University+Press&rft.issn=0021-972X&rft.eissn=1945-7197&rft.volume=105&rft.issue=3&rft.spage=e245&rft.epage=e254&rft_id=info:doi/10.1210%2Fclinem%2Fdgaa027 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0021-972X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0021-972X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0021-972X&client=summon |